Ardelyx (ARDX) Shares Outstanding (Weighted Average) (2013 - 2026)

Ardelyx (ARDX) reported Shares Outstanding (Weighted Average) of $245.9 million for Q1 2026, up 3.03% on a YoY basis from $238.6 million in Q1 2025, and up 2.0% quarter-over-quarter from $241.0 million in Q4 2025.

Ardelyx (ARDX) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends

Ardelyx has reported Shares Outstanding (Weighted Average) for 14 years, with the latest figure at $245.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 3.03% year-over-year to $245.9 million; the trailing twelve-month figure through Mar 2026 stood at $245.9 million (up 3.03% YoY), and the FY2025 full-year result was $241.0 million, up 2.47% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $245.9 million, up from $241.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $245.9 million in Q1 2026, with the low at $130.9 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $210.2 million across 5 years, with a median of $227.9 million in 2023.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) soared 64.32% — and 2025, when it advanced 2.38%.
  • Ardelyx's Shares Outstanding (Weighted Average) stood at $158.7 million in 2022, then jumped by 38.21% to $219.3 million in 2023, then advanced by 7.25% to $235.2 million in 2024, then increased by 2.47% to $241.0 million in 2025, then gained by 2.0% to $245.9 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $245.9 million (Q1 2026), $241.0 million (Q4 2025), and $239.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 245.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 245.86 Mn
Dec 31, 2025 241.03 Mn
Jun 30, 2025 239.93 Mn
Mar 31, 2025 238.62 Mn
Dec 31, 2024 235.23 Mn
Sep 30, 2024 234.52 Mn
Jun 30, 2024 233.82 Mn
Mar 31, 2024 233.07 Mn
Dec 31, 2023 219.33 Mn
Sep 30, 2023 222.78 Mn
Jun 30, 2023 211.01 Mn
Mar 31, 2023 207.02 Mn
Dec 31, 2022 158.69 Mn
Sep 30, 2022 165.10 Mn
Jun 30, 2022 145.54 Mn
Mar 31, 2022 130.94 Mn
Dec 31, 2021 104.21 Mn
Sep 30, 2021 100.48 Mn
Jun 30, 2021 100.04 Mn
Mar 31, 2021 97.18 Mn